Avalo Therapeutics
AVTX
AVTX
36 hedge funds and large institutions have $133M invested in Avalo Therapeutics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
1% less capital invested
Capital invested by funds: $135M → $133M (-$1.67M)
Holders
36
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.4M | |
| 2 | +$1.54M | |
| 3 | +$1.48M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.33M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$853K |
Top Sellers
| 1 | -$3.5M | |
| 2 | -$861K | |
| 3 | -$665K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$589K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$329K |